Katie M. Campbell
0000-0001-6491-4432
Publication & Citation Trends
Publications
0 total
Abstract 2514: Patient-driven multi-omic longitudinal research study reveals novel insights into uveal melanoma progression
Cited by 0
Semantic Scholar
Abstract 5616: Tumor necrosis factor-alpha armed TCR-T and CAR-T cells for solid tumors provide superior anticancer activity in the absence of toxicity
Cited by 0
Semantic Scholar
Abstract PR010: Genome-wide CRISPR screens in CD8+ T cells identify cullin-RING E3 ubiquitin ligase complex as a negative regulator of long-term effector function
Cited by 0
Semantic Scholar
Abstract PR006: High melanoma-specific survival in patients with desmoplastic melanoma treated with single agent anti-PD-1 in SWOG S1512
Cited by 0
Semantic Scholar
Abstract 2505: Semi-automated image registration and cell typing integrates multiplexed imaging data to investigate the tumor microenvironment in clinical biopsies
Cited by 0
Semantic Scholar
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma OA
Cited by 21
Semantic Scholar
Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
Cited by 0
Semantic Scholar
Abstract 3607: Case study: Efficacy and persistence of autologous T cell therapy targeting SLC45A2 in uveal melanoma
Cited by 0
Semantic Scholar
Correction: ERK mediates interferon gamma-induced melanoma cell death OA
Cited by 1
Semantic Scholar
Antitumor Immune Responses in B2M-Deficient Cancers. OA
Cited by 31
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(117)
CAR-T cell therapy research
(108)
Immunotherapy and Immune Responses
(69)
Cancer Genomics and Diagnostics
(59)
Monoclonal and Polyclonal Antibodies Research
(41)
Affiliations
Broad Institute
James S. McDonnell Foundation
Gynecologic Oncology Group
Pennsylvania State University
APLA Health